- Home
- ANL vs MGRM Comparison
ANL vs MGRM Comparison
Compare ANL & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- MGRM
- Stock Information
- Founded
- ANL 2004
- MGRM 2016
- Country
- ANL Cayman Islands
- MGRM United States
- Employees
- ANL N/A
- MGRM N/A
- Industry
- ANL
- MGRM Medical/Dental Instruments
- Sector
- ANL
- MGRM Health Care
- Exchange
- ANL Nasdaq
- MGRM Nasdaq
- Market Cap
- ANL 79.0M
- MGRM 89.6M
- IPO Year
- ANL 2023
- MGRM N/A
- Fundamental
- Price
- ANL $2.05
- MGRM $2.57
- Analyst Decision
- ANL Strong Buy
- MGRM Strong Buy
- Analyst Count
- ANL 2
- MGRM 1
- Target Price
- ANL $9.00
- MGRM $4.00
- AVG Volume (30 Days)
- ANL 13.8K
- MGRM 63.8K
- Earning Date
- ANL 02-24-2025
- MGRM 03-14-2025
- Dividend Yield
- ANL N/A
- MGRM N/A
- EPS Growth
- ANL N/A
- MGRM N/A
- EPS
- ANL N/A
- MGRM N/A
- Revenue
- ANL $5,000,000.00
- MGRM $364,999.00
- Revenue This Year
- ANL N/A
- MGRM N/A
- Revenue Next Year
- ANL N/A
- MGRM N/A
- P/E Ratio
- ANL N/A
- MGRM N/A
- Revenue Growth
- ANL N/A
- MGRM N/A
- 52 Week Low
- ANL $1.85
- MGRM $1.53
- 52 Week High
- ANL $17.48
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- ANL 44.92
- MGRM 54.65
- Support Level
- ANL $2.00
- MGRM $2.35
- Resistance Level
- ANL $2.19
- MGRM $2.80
- Average True Range (ATR)
- ANL 0.27
- MGRM 0.20
- MACD
- ANL -0.01
- MGRM -0.01
- Stochastic Oscillator
- ANL 16.81
- MGRM 54.00
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.